TABLE 1.
Secretory and serum IgA in patients treated with FTY and GA.
| FTY (n = 15) | GA (n = 10) | p | |
| Females (n, %) | 5 (33.3%) | 10 (100%) | p < 0.05 |
| Age in years (mean, SD) | 43.67 (SD = 7.98) | 46.40 (SD = 10.71) | p = 0.115 |
| EDSS (median, IQR) | 3.0 (2.0–4.0) | 2.0 (2.0–3.0) | p = 0.327 |
| Fecal sIgA in μg/g feces (mean, SD) | 3323.13 (SD = 2094.72) | 2040.65 (SD = 1709.07) | p = 0.411 |
| Saliva sIgA in μg/ml (median, IQR) | 667.03 (SD = 359.72) | 778.85 (SD = 288.67) | p = 0.748 |
| Leukocytes in GPt/l (mean, SD) | 4.20 (SD = 1.41) | 6.13 (SD = 1.50) | p = 0.880 |
| Lymphocytes in GPt/l (mean, SD) | 0.42 (SD = 0.17) | 1.78 (SD = 0.58) | p < 0.05 |
| Serum IgA in g/l (mean, SD) | 1.78 (SD = 0.91) | 1.78 (SD = 0.78) | p = 0.412 |
| Serum IgM in g/l (mean, SD) | 0.74 (SD = 0.26) | 1.25 (SD = 0.58) | p = 0.255 |
| Serum IgG in g/l (mean, SD) | 8.54 (SD = 1.69) | 11.58 (SD = 3.12) | p = 0.269 |